Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mater Sci Eng C Mater Biol Appl ; 103: 109753, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31349477

RESUMEN

Type 1 diabetes mellitus (DM) is a metabolic disorder associated with impaired carbohydrate metabolism. We present a promising bioinspired approach against type 1 DM using yeast microcapsule (YMC). The glucan component in the outer shell of baker's yeast undergoes receptor-mediated uptake by phagocytic cells through M cell-mediated endocytosis. Thus, a drug can be expected to be delivered to the systemic circulation via lymphatic transport if it is attached to the surface of YMC. For the first time, this possibility has been explored by surface loading of insulin onto YMC. The electrostatic interaction between oppositely charged YMC and insulin resulted in the formation of insulin-loaded yeast microcapsule (IYMC) which was confirmed by fluorescence imaging. Alginate coating provided to IYMC protects YMC from the harsh environment of the gastrointestinal tract and prevents the degradation of insulin in IYMC. Cellular uptake of FITC conjugated IYMC by RAW macrophages confirmed the proposed mechanism of insulin uptake. Moreover, an in vitro method using YMC-imprinted gel was developed for insulin release study from the bioinspired system. Molecular docking studies proved the interaction of insulin with ß-glucan and alginate. A significant hypoglycemic effect was observed after oral administration of the alginate coated insulin-loaded yeast microcapsule (AL-IYMC) in diabetic rats. The AL-IYMCs could serve as a promising approach towards the oral delivery of insulin.


Asunto(s)
Cápsulas/administración & dosificación , Sistemas de Liberación de Medicamentos/métodos , Insulina/administración & dosificación , Insulina/farmacocinética , Saccharomyces cerevisiae , Administración Oral , Alginatos , Animales , Cápsulas/química , Diabetes Mellitus Experimental/tratamiento farmacológico , Portadores de Fármacos/administración & dosificación , Portadores de Fármacos/química , Liberación de Fármacos , Hipoglucemiantes/administración & dosificación , Hipoglucemiantes/análisis , Hipoglucemiantes/farmacocinética , Insulina/análisis , Intestinos/efectos de los fármacos , Intestinos/patología , Ratones , Simulación del Acoplamiento Molecular , Imagen Molecular , Tamaño de la Partícula , Células RAW 264.7 , Ratas Sprague-Dawley , Saccharomyces cerevisiae/química , Saccharomyces cerevisiae/citología , Espectroscopía Infrarroja por Transformada de Fourier
2.
Mater Sci Eng C Mater Biol Appl ; 100: 616-630, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-30948098

RESUMEN

With advances in nanotechnology, the applications of nanomaterial are developing widely and greatly. The characteristic properties of carbon nanotubes (CNTs) make them the most selective candidate for various multi-functional applications. The greater surface area of the CNTs in addition to the capability to manipulate the surfaces and dimensions has provided greater potential for this nanomaterial. The CNTs possess greater potential for applications in biomedicine due to their vital electrical, chemical, thermal, and mechanical properties. The unique properties of CNT are exploited for numerous applications in the biomedical field. They are useful in both therapeutic and diagnostic applications. They form novel carrier systems which are also capable of site-specific delivery of therapeutic agents. In addition, CNTs are of potential application in biosensing. Many recently reported advanced systems of CNT could be exploited for their immense potential in biomedicine in the future.


Asunto(s)
Tecnología Biomédica/métodos , Nanotubos de Carbono/química , Sistemas de Liberación de Medicamentos , Técnicas de Transferencia de Gen , Nanotubos de Carbono/toxicidad , Nanotubos de Carbono/ultraestructura , Medicina Regenerativa , Ingeniería de Tejidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA